reputable tirzepatide compounding pharmacy FDA says pharmacies can keep making weight-loss med tirzepatide, for now Compounded tirzepatide telehealth from Fitish RX Compounded Tirzepatide for Women |

Weight loss is typically non-linear, with rates varying throughout treatment rather than occurring at a fixed weekly rate

Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling

SURMOUNT-1 Trial Results (Published in New England Journal of Medicine): According to the SURMOUNT-1 clinical trial enrolling 2,539 participants, tirzepatide achieved the following mean weight reductions at 72 weeks: 5 mg dose: 16.0% mean weight loss (approximately 35 lbs or 16 kg) 10 mg dose: 21.4% mean weight loss (approximately 49 lbs or 22 kg) 15 mg dose: 22.5% mean weight loss (approximately 52 lbs or 24 kg) Placebo: 2.4% mean weight loss (approximately 5 lbs or 2 kg) According to the trial data, 89% to 96% of participants taking tirzepatide at the 10 mg and 15 mg doses achieved at least 5% body weight reduction, compared to 28% of those taking placebo

The OSU faculty/staff plan dropped weight-loss GLP-1s entirely on January 1, 2026

We understand that every patients journey is different, which is why we offer personalized weight loss plans designed specifically for you

It also offers high amounts of B vitamins along with hard-to-get micronutrients like selenium and choline